Polycystic ovary syndrome (PCOS) is an endocrine disorder that occurs in 8-10% of women of reproductive age. It is characterized by oligo or anovulation, hyperandrogenism and/or polycystic ovaries, but also by an increased insulin plasma level especially in overweight/obese women or in those with familial diabetes. In the last years, among the insulin sensitizers, the use of the two active isoforms of inositols (myo-inositol and d-chiro-inositol) has been spreading for the treatment of PCOS insulin resistance. Several studies have shown a positive role of inositols both on the metabolic profile of PCOS patients, but also on hormonal parameters. Hence, inositols can positively affect the infertility that characterizes many PCOS patients, acting both on ovarian function and spontaneous ovulation and during IVF procedures, in terms of oocyte quality and pregnancy rate.
The relevance of inositols treatment for PCOS before and during ART / Artini, P. G.; Malacarne, E.; Tomatis, V.; Genazzani, A. D.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 25:14(2021), pp. 4799-4809. [10.26355/eurrev_202107_26393]
Data di pubblicazione: | 2021 | |
Titolo: | The relevance of inositols treatment for PCOS before and during ART | |
Autore/i: | Artini, P. G.; Malacarne, E.; Tomatis, V.; Genazzani, A. D. | |
Autore/i UNIMORE: | ||
Digital Object Identifier (DOI): | http://dx.doi.org/10.26355/eurrev_202107_26393 | |
Rivista: | ||
Volume: | 25 | |
Fascicolo: | 14 | |
Pagina iniziale: | 4799 | |
Pagina finale: | 4809 | |
Codice identificativo ISI: | WOS:000680162900021 | |
Codice identificativo Scopus: | 2-s2.0-85111220030 | |
Citazione: | The relevance of inositols treatment for PCOS before and during ART / Artini, P. G.; Malacarne, E.; Tomatis, V.; Genazzani, A. D.. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 25:14(2021), pp. 4799-4809. [10.26355/eurrev_202107_26393] | |
Tipologia | Articolo su rivista |
File in questo prodotto:
Pubblicazioni consigliate

I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris